Among the 21 transcripts with PCR confirmation, the expression of FRAT2, TNFRSF19, ACP7, IRS4, PLEKHG4B, KRT17, ZNF703, and CAV2 was significantly higher in MED12-mutation-positive specimens as compared to MED12-mutation-negative ones (Leiomyoma/paired Myometrium; Supplementary Figure S4). This evidence concerns the gene TNFRSF19 and leiomyoma.